Answers are grounded in this paper and cite their sources.
Inverted Schneiderian papilloma (ISP) is a relatively rare tumor of epithelial origin, comprising 0.5% to 4% of sinonasal tumors.1 These tumors are primarily benign but locally aggressive; however, they also possess the potential for malignant transformation. Studies disagree on the incidence of transformation (1%–53% by various accounts2), but most evidence supports an 11% to 15% incidence.2 Certain studies suggest an etiological association of ISP with human papilloma virus (HPV),3 whereas other authors contend that HPV presence more likely represents incidental infection.4 ISP also has a significant potential for recurrence after resection. A case of recurrent ISP presenting as a middle ear mass, with features of malignant transformation to squamous cell carcinoma (SCC) is reported. Resection of this patient's extensive tumor necessitated eustachian tube (ET) resection by way of a combined endonasal and transmastoid approach. A 69-year-old female was referred to our clinic for evaluation of a middle ear mass. She had previously undergone resection of a nasal cavity mass diagnosed as invasive SCC arising in ISP. Twelve months after initial resection of that tissue and after adjuvant chemoradiation treatment, she returned with conductive hearing loss and a mass in the middle ear. Biopsy of the middle ear mass revealed tissue consistent with recurrent disease, and further imaging suggested tumor extending from the nasal cavity to the middle ear via the ET. This was deemed unresectable at the outside hospital. At the time of presentation to our clinic, the patient overall felt well. She had experienced no weight loss, pain, headache, visual changes, diplopia, or changes in sensation in her face. Examination revealed polypoid tissue filling the medial third of the right external auditory canal (EAC) and middle ear. The left ear was normal. Endoscopic examination of the nasal cavity revealed postoperative changes on the right with openings of the inferior portions of the anterior and posterior ethmoids. Polypoid changes were noted along the superior aspect of the inferior turbinate extending from the uncinate process. The maxillary sinus was poorly visualized. The right ET orifice and tubal lumen (∼1 cm deep) showed no obvious abnormalities. Further work-up included repeat biopsy, additional CT scans of the sinuses and temporal bone (Fig. 1A–C), magnetic resonance imaging (MRI) (Fig. 1D), and an audiogram. The images revealed middle and mastoid opacity including the ET without erosion. ET penetration appeared probable based on the temporal bone CT scan (Fig. 1C). The results of repeat biopsy revealed papillary SCC in situ. HPV typing was not performed. Some opacification was also present in the mastoid air cells at the petrous apex, which were thought to represent either tumor or obstructive changes. Audiometric testing revealed a conductive hearing loss. Axial T1 MRI with contrast (A) shows an enhancing, heterogeneous mass. Coronal non-contrast T1 MRI (B) and coronal CT (C) show a mass occupying the R maxillary sinus (arrows). Temporal bone CT (D) shows middle ear mass with extension into the external auditory canal and opacification of the mastoid. A single-stage, two-team operation was planned. The first team, an endoscopic anterior skull base team, would perform a complete resection of the pterygopalatine fossa (PPF), pterygoid plates, and cartilaginous ET. Subsequently, a neuro-otologic team would perform a subtotal temporal bone resection, including the external auditory canal, tympanic membrane, malleus, incus, and bony ET excavation along the horizontal and vertical petrous carotid artery to communicate with the transnasal resection. The external auditory meatus would be managed with blind sac closure. An overview diagram of the surgical approaches is provided in Figure 2. Targeted intraoperative radiotherapy was also planned following resection. Diagram of eustachian tube with tracings of areas of surgical resection. (Adapted from Dr. Timothy Hain at http://www.dizziness-and-balance.com/images/master-ear.jpg. Accessed January 16, 2012. Used as per noncommercial permission granted on their site. The authors thank Dr. Hain for use of the background image for demonstration of their path of resection.) The patient was brought to the operating room and placed under general anesthesia in the supine position. CT image guidance was registered to the patient and accuracy was confirmed. Facial nerve monitoring probes were placed in the orbicularis oris and orbicularis oculi and were confirmed to be functional prior to initiation of surgery. To combat oropharyngeal flora potentially introduced into the mastoid during the procedure, the patient received intravenous cefazolin preoperatively and during her hospital stay, and per os cephalexin upon discharge. Additionally, copious irrigation was used to prepare the nose prior to ET resection and during the entire case to keep the field as clean as possible. The right neck was prepped and the carotid bifurcation was marked. A 7-cm incision was marked for carotid access and vascular control in the event of a carotid injury. The carotid bulb was also marked, providing a target below this point for digital pressure to be applied below to the common carotid. We also had extensive discussion with the anesthesia team regarding risk to the carotid, with a plan for blood replacement in the room. We discussed a goal of maintaining normotensive blood pressure in the event of a carotid injury. Although it seems counterintuitive to maintain a mean arterial pressure of 80 mm Hg during a carotid injury, hypotension can cause stroke secondary to cerebral hypoperfusion if carotid flow is interrupted. Hypotension is only indicated if vascular control cannot be gained with a normal pressure. Had a carotid injury occurred, we planned to have both experienced skull base surgeons work together to regain carotid control with primary repair as our goal. The operation began with an endoscopic medial maxillectomy with the residual inferior and middle turbinates removed. The nasolacrimal duct was sharply transsected. This allowed the team to drill out the posterior maxillary wall for access to the PPF. The internal maxillary artery was clipped and transected, and the PPF contents were removed with bipolar and sharp dissection to the level of V2. Both pterygoid plates were then drilled away, allowing access to the ET. The nasopharyngeal fascia was dissected posteriorly and brought forward with the cartilaginous ET. After mobilization from foramen lacerum, the petrous carotid, and the paraspinal muscles, the entire cartilaginous ET and accompanying mucosal contents were transected with margins sent. The neuro-otologic team initially performed a lateral temporal bone resection preserving the facial nerve. The EAC was oversewn. Tumor filled the mastoid antrum and middle ear, although the remaining mastoid was free. The tumor appeared to be mostly nonadherent to the mucosa and dissected easily to the protympanic bony ET. The bony ET was then drilled to the level of the horizontal and vertical carotid artery medially and anteriorly. The bone between the glenoid fossa and carotid artery was removed and extended anteriorly. The tensor tympani canal and muscle was resected, middle fossa dura identified, and the cartilaginous ET resection margin from the transnasal approach identified. Thus, the entire bony and cartilaginous ET was resected and gross total tumor removal accomplished. Margins were sent for frozen section from the soft tissue areas and were confirmed to be negative. The temporal bone specimen margins were sent as permanent specimens and noted negative on final pathology. No carotid or cranial nerve injuries, or cerebrospinal fluid leaks were noted. A Jackson-Pratt drain was placed, and the mastoid cavity, ET, and middle ear were obliterated with abdominal fat. Anteriorly, absorbable collagen sponge (Gelfoam; Baxter Healthcare Corp., Hayward, CA) was placed over the exposed PPF and pterygoid muscles, and a Foley balloon applied compression of the pterygoid venous plexuses. Anterior reconstruction of the transpterygoid endonasal defect was not performed to allow for endoscopic surveillance. Final pathological evaluation of resected tissue revealed ISP with areas of squamous dysplasia and SCC in situ. ISP with moderate to severe dysplasia was noted in tissue resected from the maxillary sinus and mastoid antrum despite the negative physical examination. These results were interpreted as either SCC in situ arising within a background of Schneiderian papilloma versus papillary SCC. Margins were confirmed negative. The patient recovered well postoperatively. She was initially monitored in the intensive care unit, but had no complications and was transferred to the floor on postoperative day 1. The patient was taught trismus exercises in the early postoperative period. Nasal Foley was removed on postoperative day 3 without resultant epistaxis, and the patient was discharged thereafter. The patient has been followed for 3 years postoperatively with serial endoscopic examinations every 3 to 6 months without evidence of recurrence. She experienced no postoperative vertigo, although she did have the expected ipsilateral maximal conductive hearing loss. Since early in the postoperative period, she has performed twice daily nasal irrigations (NeilMed, Santa Rosa, CA). A planned transmastoid and endonasal second-look procedure was performed 3 months postoperatively (Fig. 3), with negative biopsies. Given persistently reassuring findings, additional adjuvant therapy was not deemed necessary. Repeat MRI and clinic endoscopy performed at the time of her most recent follow-up visit—3 years after her surgery—revealed no evidence of recurrent disease (Fig. 4). Intraoperative images from planned second look procedure, performed 3 months after initial resection. (A) Unlabeled endoscopic view of the of the medial maxillectomy and transpterygoid defect, looking at the area of the eustachian tube (ET) resection. The divot at the base of the ET resection site is the healing opening of the drilled-out bony and cartilaginous ET junction. (B) Labeled image of the same view. SS = dissected and open sphenoid sinus; PPF = lateral margin of the resected pterygopalatine fossa; ET and adjacent marking = native position of the ET prior to resection. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] Follow-up magnetic resonance imaging with contrast performed 3 years after initial resection. Axial (A) and coronal (B) views. The middle ear and nasopharyngeal portions of the ET on the right side show a resection defect. A medial maxillectomy defect is also present. There is no evidence of recurrence. Inverted papilloma typically arises in the nose or paranasal sinuses. However, rare cases have been described within various sites including the oral cavity,5 palatine tonsil,6 and nasolacrimal system.7 Intracranial and orbital extension is occasionally encountered.7, 8 In the case described above, the patient had a recurrent ISP that presented as a middle ear mass with resultant conductive hearing loss. Such a presentation is extremely rare; according to recent reviews, fewer than 25 cases ISP of the middle ear have heretofore been described.9, 10 Typically, surgical management has included radical mastoidectomy without addressing the ET. With such an approach, recurrence rates have been very high: 50% to 60% for all disease and 69% when specifically considering malignant lesions.10 Of the reviewed literature, we found only one other description of a concurrent endonasal and mastoid resection.9 Of note, that case did not describe ET dissection, and the patient experienced a recurrence within 2 months of initial resection. No other authors specifically address dissection of the ET to eliminate disease from the presumed route of spread. Thus, this resection constitutes a novel approach for a tumor invading the middle ear cavity via migration up the ET. In complex cases of pathology of the head and neck, intimate knowledge of relevant anatomy is paramount. Resections such as this one demand comprehensive preoperative planning. In particular, discussion of and preparedness for potential complications is critical. This surgical approach traverses territory in which management of the carotid artery becomes a key issue. Extensive familiarity with the anatomy as well as careful dissection enabled our team to avoid injury to this vital structure; however, we were prepared throughout the procedure to address this potential complication should it arise. Collaborative approaches such as this one may provide superior therapeutic options to otherwise challenging pathology. ISP presenting as a middle ear mass is exceedingly rare. This case illustrates successful complete resection via combined transtemporal and expanded endonasal surgical approaches. To our knowledge, this two-team approach for addressing ET disease is undocumented in the literature. Although the effectiveness of this approach remains to be established for both ISP and other pathologies, its success is noteworthy and merits further consideration. Specifically, the morbidity profile of the described approach when compared to that of an open approach of similar scope is clearly advantageous. Importantly, this case underscores the need for a combined, multidisciplinary team approach to skull base lesions. A variety of seemingly unrelated management options can be combined to serve the patient's best interests in complex cases such as the one presented here. Lesions of the petrous apex, clivus, and infratemporal fossa fall within the purview of both otologic/lateral and rhinologic/anterior skull base surgeons, and mutual cooperation through team integration is critical for successful patient care.
No takes yet. Share an insight, caveat, or question.
Mitchell et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: